Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB2962

Introduced
9/28/23  

Caption

Drive American Act

Impact

The repeal of the current tax credits for electric vehicles is anticipated to have profound implications on the clean vehicle market. Supporters of SB2962 argue that it aims to reassess the balance between electric and traditional vehicle incentives, arguing that it would support job growth by favoring domestic manufacturing over foreign electric vehicle manufacturers. However, critics are concerned that removing tax incentives for electric vehicles could hinder the adoption of environmentally friendly transportation options, negatively impacting efforts to reduce carbon emissions and combat climate change.

Summary

Senate Bill 2962, known as the 'Drive American Act', proposes the repeal of existing tax incentives for electric vehicles while introducing a new tax credit intended to boost automobile manufacturing within the United States. The bill represents a significant shift in federal automotive policy, particularly as it relates to electrification and American manufacturing capabilities. By removing incentives for electric vehicles, proponents argue that it would level the playing field for traditional automobile manufacturing, specifically targeting production jobs in the U.S. The allowance for an 'America First Vehicle Credit' aims to promote vehicles manufactured with a substantial amount of U.S.-sourced materials and labor.

Contention

Key points of contention surrounding SB2962 include the broader implications of ending support for electric vehicles—which some view as essential to fostering a sustainable future—versus the immediate economic benefits of increased jobs in traditional vehicles. Additionally, stipulations regarding the qualifications for the new tax credit raise questions about how 'American-made' a vehicle must be to qualify. This contentious debate also includes discussions on regional content requirements and labor value percentages that manufacturers must meet, which could exclude many vehicles from receiving the new credit.

Companion Bills

US SB3016

Related End Taxpayer Subsidies for Electric Vehicles Act

Similar Bills

US SB882

Patients Before Middlemen Act

US HB8385

Baby Food Safety Act of 2024

US HB5564

REDUCE Act of 2023 Rewarding Efforts to Decrease Unrecycled Contaminants in Ecosystems Act of 2023

US SB2844

REDUCE Act of 2023 Rewarding Efforts to Decrease Unrecycled Contaminants in Ecosystems Act of 2023

US HB1293

Vehicle Energy Performance Act of 2025

US HB8380

VITAL Act of 2024 Vaccines In Trial And Liability Act of 2024

US HB8187

Critical Material Transparency and Reporting in Advanced Clean Energy Act of 2024

US HB2554

Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).